The World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) have clearly described the significant role of pharmacists in the increasing demands for health. The emergence of the Global Pharmacist aims to define, promote and recommend the need to go beyond the pharmacist’s traditional role of drug dispensing to being an integral part of the health care team. This means that pharmacists feel the need to pursue advanced knowledge and competencies to be adept in addressing global health threats such as antimicrobial resistance, medicine shortages, poor quality of medicines, and more.

Empower School of Health, along with FIP, are hosting a webinar on 29 October on "Transforming Global Health and the Role of the Global Pharmacist". The objective of this webinar is to breakdown the different roles that can be played by a pharmacist and explore how they can develop relevant competencies to aid them in this career transformation

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Objective
Identifying mechanisms for transforming vaccination using FIP DG7: Advancing integrated services

Moderator:
Marwan Akel, Chairperson Pharmacy Practice Department Lebanese International University - Lebanon

Panellists:
1.Barbel Holbein, Lecturer and Researcher University of Bremen; University of applied sciences-Baden Württemberg - Germany
2.Sofía Segura, Professor University of Costa Rica and College of Pharmacists of Costa Rica - Costa Rica
3. Pamela Logan, Director of Pharmacy Services Irish Pharmacy Union - Ireland

Summary or description of digital event (Maximum 100 words) The objective of this webinar is to present a summary of the most innovative research in pharmacy practice and to discuss its contribution to the pharmacy profession.

Four key speakers from Research in Social and Administrative Pharmacy will present their research in the webinar. The topics covered will involve pharmacists prescribing, implementation of professional pharmacy services, roles of pharmacists during the COVID-19 pandemic and innovative models for pharmacists providing medication reviews.

The potential audience for this webinar will be practitioners with an interest in pharmacy practice research, novel and experienced researchers.

Learning objectives:
To identify how pharmacy practice research can contribute to the practice of pharmacy
To discuss how research can inform innovate pharmacy models of care
To discuss pharmacy practice research priority areas
FIP Organizers and/or external partners

Moderator:
Victoria Garcia Cardenas, Senior Lecturer University of Technology Sydney Research in Social and Administrative Pharmacy - Australia

Panellists:
1. Shane Desselle, Professor, Editor in Chief Touro University Research in Social and Administrative Pharmacy - USA
2. Karen Luetsch, Lecturer the University of Queensland - Australia
3. Carolina Ung, Professor University of Macau - China
4. Derek Stewart, Professor of Clinical Pharmacy and Practice - Qatar University - Qatar
5. Sherilyn Houle, Professor University of Waterloo - Canada

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Outcomes
To understand the impact of FIP Development Goal 13: Policy Development in the Transformation of Vaccination Globally and Regionally

Moderators:
Ellen Schafheutle, Professor of Pharmacy Policy and Practice Centre for Pharmacy Workforce Studies, The University of Manchester - United Kingdom
Chima Amadi, Education and Training Personnel Pharmacists’ Council Nigeria - Nigeria

Panellists:
1. Walter da Silva João, President Brazilian Federal Council of Pharmacy - Brazil
2. Howard Rice, Hon. President & International Liaison Officer Pharmaceutical Association of Israel - Israel
3. Shane Jackson, Community and Consultant Pharmacist - Pharmaceutical Society of Australia - Australia

Se generó, durante esta pandemia, diversos tipos de evidencia respecto a los tratamientos para la Covid-19 pero aún así, el farmacéutico se enfrenta a la necesidad de tomar decisiones en ausencia de evidencia científica. Para apoyar la toma de decisiones, se compartirán los caminos emprendidos en el Hospital G. Marañón para la selección y protocolización del tratamiento para Covid-19 mostrando las herramientas utilizadas. La segunda parte será dedicada a los sistemas de farmacovigilancia (FV) sostenibles. La FV no es una actividad de lujo sino que es la base del uso seguro de medicamentos. Involucrar al paciente. Uso off-label de medicamentos.

1. Identificar los principales retos en la selección y protocolización de los tratamientos para Covid-19 en un contexto de falta de evidencia científica.
2. Analizar rol de las agencias reguladoras, la Comisión de Farmacia y Terapéutica del hospital, el grupo de expertos Covid-19 y grupo PROA del hospital y el farmacéutico en enfermedades infecciosas.
3. Compartir la experiencia en el abordaje de la selección y protocolización del tratamiento para Covid-19.
4. Discutir estrategias para organizar sistemas sostenibles para la gestión de riesgos de productos farmacéuticos y dispositivos médicos en la farmacia hospitalaria post-Covid.

Moderadora:
Nora Gerpe, Química Farmacéutica Asociación de Química y Farmacia del Uruguay-Uruguay

Panelistas:
Carmen Rodriguez, Farmacéutica Hospitalaria Hospital General Universitario Gregorio Marañón - España
Lucila Castro Pastrana, Full Professor Universidad de las Américas, Puebla - México

Aim
To describe an evidence-based approach to self-care of mild COVID-19 symptoms

Learning Objectives:
• Describe approaches for preventing the spread of COVID-19
• List symptoms of COVID-19 – similarities and differences to influenza;
• Identify myths associated with self-care of COVID-19.
• Describe how mild symptoms such as fever and pain should be managed;
• Discuss when to refer more serious cases (escalating care in COVID-19).

Target audience – all those involved in the primary health care response to the coronavirus pandemic

Programme:
1. Welcome – Moderator Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation

2. COVID-19: preventing its spread and understanding its symptoms – Jaime Acosta-Gómez, Community Pharmacist and Pharmacy Owner, Spain

3. Dispelling myths about self-care treatments of COVID-19 – Christopher John, FIP Lead for Data and Intelligence

4. How to manage mild symptoms – self-care case study. Lars-Åke Söderlund, President FIP Community Pharmacy Section

5. Panel Discussion – questions and answers – All speakers